These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 37020494)

  • 41. Comparison of the analytical and clinical performance of five tests for the detection of human papillomavirus genital infection.
    Del Pino M; Alonso I; Rodriguez-Trujillo A; Bernal S; Geraets D; Guimerà N; Torne A; Ordi J
    J Virol Methods; 2017 Oct; 248():238-243. PubMed ID: 28739302
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluation of ILEX SelfCerv for Detection of High-Risk Human Papillomavirus Infection in Gynecology Clinic Attendees at a Tertiary Hospital in South Africa.
    Tiiti TA; Mashishi TL; Nkwinika VV; Molefi KA; Benoy I; Bogers J; Selabe SG; Lebelo RL
    J Clin Med; 2021 Oct; 10(21):. PubMed ID: 34768334
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical performance of the CLART human papillomavirus 2 assay compared with the hybrid capture 2 test.
    Pista A; Verdasca N; Oliveira A
    J Med Virol; 2011 Feb; 83(2):272-6. PubMed ID: 21181922
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Head-to-head comparison of genotyping of human papillomavirus by real-time multiplex PCR assay using type-specific primers and SPF10-PCR-based line probe assay.
    Yin J; Peng S; Zhang C; Li X; Hu F; Chen W; Qiao Y
    J Med Virol; 2023 Feb; 95(2):e28579. PubMed ID: 36786174
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Detection and genotyping of HPV in urine samples from Chilean women attending primary health care centers.
    Vergara N; Balanda M; Hidalgo W; Martín HS; Aceituno A; Roldán F; Villalón T; Hott M; Espinoza G; Quiero A; Valenzuela MT; Ramírez E
    Med Microbiol Immunol; 2018 Apr; 207(2):95-103. PubMed ID: 29238853
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Application of isothermal HPV DNA amplification test in cervical cancer screening].
    Wang L; Jiang MY; Qin Y; Li L; Wu ZN; Li TY; Wu T; Chen W
    Zhonghua Zhong Liu Za Zhi; 2018 Apr; 40(4):313-318. PubMed ID: 29730922
    [No Abstract]   [Full Text] [Related]  

  • 47. High-risk human papillomavirus detection in self-collected vaginal samples compared with healthcare worker collected cervical samples among women attending gynecology clinics at a tertiary hospital in Pretoria, South Africa.
    Tiiti TA; Mashishi TL; Nkwinika VV; Benoy I; Selabe SG; Bogers J; Lebelo RL
    Virol J; 2021 Sep; 18(1):192. PubMed ID: 34556128
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Prevalence and Genotype of Human Papillomavirus from Patients with Genital Warts in Eastern Guangdong Province.
    Luo ZY; Chen Q; Yang H; Lin M; Chen CY; Yang C; Yang LY
    Asian Pac J Cancer Prev; 2015; 16(14):5675-9. PubMed ID: 26320434
    [TBL] [Abstract][Full Text] [Related]  

  • 49. HPV molecular detection from urine versus cervical samples: an alternative for HPV screening in indigenous populations.
    Torres-Rojas FI; Mendoza-Catalán MA; Alarcón-Romero LDC; Parra-Rojas I; Paredes-Solís S; Leyva-Vázquez MA; Cortes-Arciniega JE; Bracamontes-Benítez CJ; Illades-Aguiar B
    PeerJ; 2021; 9():e11564. PubMed ID: 34178456
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Can human papillomavirus DNA testing of self-collected vaginal samples compare with physician-collected cervical samples and cytology for cervical cancer screening in developing countries?
    Bhatla N; Dar L; Patro AR; Kumar P; Kriplani A; Gulati A; Iyer VK; Mathur SR; Sreenivas V; Shah KV; Gravitt PE
    Cancer Epidemiol; 2009 Dec; 33(6):446-50. PubMed ID: 19931499
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Detection of human papillomavirus in urine among heterosexual men in relation to location of genital warts and circumcision status.
    Aung ET; Fairley CK; Tabrizi SN; Danielewski JA; Ong JJ; Chen MY; Bradshaw CS; Chow EPF
    Sex Transm Infect; 2018 May; 94(3):222-225. PubMed ID: 28866637
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study.
    Castle PE; Stoler MH; Wright TC; Sharma A; Wright TL; Behrens CM
    Lancet Oncol; 2011 Sep; 12(9):880-90. PubMed ID: 21865084
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Spectrum of genital human papillomavirus infection in a female adolescent population.
    Jamison JH; Kaplan DW; Hamman R; Eagar R; Beach R; Douglas JM
    Sex Transm Dis; 1995; 22(4):236-43. PubMed ID: 7482107
    [TBL] [Abstract][Full Text] [Related]  

  • 54. High-Risk Human Papillomavirus Detection in Urine Samples From a Referral Population With Cervical Biopsy-Proven High-Grade Lesions.
    Lorenzi AT; Fregnani JHT; Dockter J; Fitzgerald K; Strohecker E; Eaton B; Vibat CRT; Erlander MG; Scapulatempo-Neto C; Smith JS; Longatto-Filho A
    J Low Genit Tract Dis; 2018 Jan; 22(1):17-20. PubMed ID: 29271852
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Urine collection in cervical cancer screening - analytical comparison of two HPV DNA assays.
    Tranberg M; Jensen JS; Bech BH; Andersen B
    BMC Infect Dis; 2020 Dec; 20(1):926. PubMed ID: 33276740
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical validation of full genotyping CLART® HPV4S assay on SurePath and ThinPrep collected screening samples according to the international guidelines for human papillomavirus test requirements for cervical screening.
    Ejegod DM; Lagheden C; Bhatia R; Pedersen H; Boada EA; Sundström K; Cortés J; Josë FXB; Cuschieri K; Dillner J; Bonde J
    BMC Cancer; 2020 May; 20(1):396. PubMed ID: 32375689
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Feasibility and Accuracy of Menstrual Blood Testing for High-risk Human Papillomavirus Detection With Capture Sequencing.
    Zhang J; Tian X; Chen Y; Huang S; Cui Z; Tian R; Zeng Z; Liang W; Gong Q; Shang R; Hu Z; Cao C
    JAMA Netw Open; 2021 Dec; 4(12):e2140644. PubMed ID: 34940863
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Self-sampling for human papillomavirus DNA detection: a preliminary study of compliance and feasibility in BOLIVIA.
    Surriabre P; Allende G; Prado M; Cáceres L; Bellot D; Torrico A; Ustariz K; Rojas S; Barriga J; Calle P; Villarroel L; Yañez RM; Baay M; Rodriguez P; Fontaine V
    BMC Womens Health; 2017 Dec; 17(1):135. PubMed ID: 29273032
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prevalence and genotyping of high risk human papillomavirus in cervical cancer samples from Punjab, Pakistan.
    Siddiqa A; Zainab M; Qadri I; Bhatti MF; Parish JL
    Viruses; 2014 Jul; 6(7):2762-77. PubMed ID: 25036463
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Self-collected versus clinician-collected cervical samples for the detection of HPV infections by 14-type DNA and 7-type mRNA tests.
    Aranda Flores CE; Gomez Gutierrez G; Ortiz Leon JM; Cruz Rodriguez D; Sørbye SW
    BMC Infect Dis; 2021 May; 21(1):504. PubMed ID: 34058992
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.